Connect with us

Hi, what are you looking for?

News

Arkema: This French Chemical Company Is Now Cheap Enough To Go Long (OTCMKTS:ARKAF)

This article was written by

The Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon. He strongly believes a portfolio should consist of a mixture of dividend and growth stocks.

He is the leader of the investment group European Small Cap Ideas which offers exclusive access to actionable research on appealing Europe-focused investment opportunities not found elsewhere. The a focus is on high-quality ideas in the small-cap space, with emphasis on capital gains and dividend income for continuous cash flow. Features include: two model portfolios – the European Small Cap Ideas portfolio and the European REIT Portfolio, weekly updates, educational content to learn more about the European investing opportunities, and an active chat room to discuss the latest developments of the portfolio holdings. Learn more.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I have no position in Arkema’s common shares, but I have written some put options which may allow me to initiate a long position when they expire in the money.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

News

This article was written by Follow Samuel Smith has a diverse background that includes being lead analyst and Vice President at several highly regarded...

News

This article was written by Follow I specialize in constructing investment portfolios aimed at generating additional income through dividends. My focus lies on identifying...

News

This article was written by Follow I am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge,...

News

Listen below or on the go on Apple Podcasts and Spotify Nonfarm payrolls are seen up 200K for November. (0:18) Salesforce leads the smaller...